Optimal duration of dual antiplatelet therapy following percutaneous coronary intervention: protocol for an umbrella review

INTRODUCTION: Although dual antiplatelet therapy (DAPT) is routinely given to patients after percutaneous coronary intervention (PCI) with stenting, the optimal duration is unknown. Recent evidence indicates there may be benefits in extending the duration beyond 12 months but such decisions may incr...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:BMJ Open
Autores principales: Elliott, Jesse, Kelly, Shannon E, Bai, Zemin, Liu, Wenfei, Skidmore, Becky, Boucher, Michel, So, Derek Y F, Wells, George A
Formato: Artigo
Lenguaje:Inglês
Publicado: BMJ Publishing Group 2017
Materias:
Cardiovascular Medicine
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5387937/
https://ncbi.nlm.nih.gov/pubmed/28377396
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2016-015421
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares